Neith Corporation (TPEX:6236)
Taiwan · Delayed Price · Currency is TWD 17.05
0.00 (0.00%)
Jul 7, 2026, 12:01 PM CST
Neith Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 32.03 | 36.15 | 45.57 | 39.9 | 32.06 | 31.39 |
Revenue Growth | -33.67% | -20.68% | 14.20% | 24.47% | 2.13% | -28.24% |
Gross Profit Gross Profit Growth | 26.64 | 30.16 | 33.72 | 18.02 | 13.37 | 14.51 |
Operating Income Operating Income Growth | -2.68 | -0.92 | -24.89 | -48.85 | -29.05 | -8.72 |
Net Income Net Income Growth | 0.48 | 3.16 | -16.88 | -40.03 | -23.69 | -5.35 |
Earnings Per Share EPS Growth | 0.01 | 0.08 | -0.41 | -0.96 | -0.73 | -0.17 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Information Department Information Department Growth | 51.78 | 55.02 | 56.57 | 19.32 | 4.12 | - |
Adjustments and Eliminations Adjustments and Eliminations Growth | -19.76 | -19.76 | -13.99 | - | -0.04 | - |
Biotech Medical Sector Biotech Medical Sector Growth | - | 0.88 | 2.99 | 17.36 | 27.84 | 31.05 |
Total Total Growth | 32.03 | 36.15 | 45.57 | 39.9 | 32.06 | 31.39 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 140.81 | 141.21 | 133.09 | 153.85 | 181.78 | 36.07 |
Total Debt Total Debt Growth | 6.26 | 7 | 9.92 | 3.54 | 10.42 | 1.19 |
Net Cash (Debt) Net Cash Growth | 134.55 | 134.21 | 123.17 | 150.31 | 171.37 | 34.88 |
Net Cash Growth | 5.79% | 8.96% | -18.05% | -12.29% | 391.29% | 41.50% |
Net Cash Per Share Net Cash Per Share Growth | 3.23 | 3.22 | 2.96 | 3.61 | 5.31 | 1.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6.44 | 9.29 | -27.99 | -17.64 | -26.46 | 7.47 |
Capital Expenditures CapEx Growth | - | - | - | - | -7.37 | -1.5 |
Free Cash Flow Free Cash Flow Growth | 6.44 | 9.29 | -27.99 | -17.64 | -33.83 | 5.96 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 83.17% | 83.45% | 73.99% | 45.16% | 41.72% | 46.22% |
Operating Margin | -8.36% | -2.55% | -54.61% | -122.43% | -90.63% | -27.78% |
Pretax Margin | 1.48% | 8.74% | -37.05% | -100.33% | -74.25% | -17.05% |
Profit Margin | 1.48% | 8.74% | -37.05% | -100.33% | -73.89% | -17.05% |
FCF Margin | 20.10% | 25.70% | -61.42% | -44.22% | -105.53% | 19.00% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 1495.16 | 284.25 | - | - | - | - |
P/FCF Ratio | 110.33 | 96.63 | - | - | - | 61.05 |
PS Ratio | 22.17 | 24.84 | 27.33 | 35.96 | 16.79 | 11.60 |